NDAORALCAPSULE
Approved
May 1982
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
SODIUM IODIDE I 123 (sodium iodide i 123) by Integrated Biosciences is clinical pharmacology sodium iodide i 123 is readily absorbed from the upper gastrointestinal tract. First approved in 1982.
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Sodium Iodide I-123 is a radioiodine diagnostic agent administered orally as a capsule for thyroid imaging and functional assessment. It is rapidly absorbed from the gastrointestinal tract, concentrated by the thyroid gland, and used to measure thyroid function and visualize thyroid anatomy. The drug works by leveraging the thyroid's natural iodine uptake mechanism to provide diagnostic information about normal and abnormal thyroid tissue.
LOE Approaching
As a long-approved diagnostic agent approaching LOE, this product faces moderate competitive pressure (30/100) with limited growth opportunity and a likely small, stable commercial team focused on maintenance.
Mechanism of Action
CLINICAL PHARMACOLOGY Sodium Iodide I 123 is readily absorbed from the upper gastrointestinal tract. Following absorption, the iodide is distributed primarily within the extracellular fluid of the body. It is trapped and organically bound by the thyroid and concentrated by the stomach, choroid…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on Sodium Iodide I-123 offers stability in a mature diagnostic space but limited growth trajectory; ideal for professionals seeking regulatory stewardship, compliance, or maintenance-focused commercial roles rather than launch or expansion opportunities. Career progression may be constrained by the product's LOE status and modest market size.
Worked on SODIUM IODIDE I 123 at Integrated Biosciences? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.